ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's International, Phase III Clinical Study prnasia
April 27, 2020On April 8, 2020, Shanghai?Green Valley Pharmaceuticals, China received the formal?decision letter from the US Food and Drug Administration (FDA)?on the Investigational New Drug (IND) application for the GV-971 international multi-center?Phase III clinica -
US approves Chinese drug maker Shanghai Green Valley’s Alzheimer’s therapy for large-scale clinical trials SCMP
April 27, 2020A Chinese drug maker has received approval from the Food and Drug Administration to start clinical trials in the US for a breakthrough Alzheimer’s drug as it seeks global validation for the controversial therapy.
Pharma Sources Insight January 2025
